Pathway-targeted pharmacogenomics of CYP1A2 in human liver

被引：0
|
作者：
Klein, K. [1 ]
Winter, S. [1 ]
Turpeinen, M. [1 ]
Schwab, M. [1 ,2 ]
Zanger, U. M. [1 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol Ce, Stuttgart, Germany
[2] Univ Hosp Tuebingen, Inst Expt & Clin Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2011年 / 383卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [1] Pathway-targeted pharmacogenornics of CYP1A2 in human liver
    Klein, Kathrin
    Winter, Stefan
    Turpeinen, Miia
    Schwab, Matthias
    Zanger, Ulrich M.
    FRONTIERS IN PHARMACOLOGY, 2010, 1
  • [2] Delayed ontogenesis of CYP1A2 in the human liver
    Sonnier, M.
    Cresteil, T.
    European Journal of Biochemistry, 251 (03):
  • [3] Delayed ontogenesis of CYP1A2 in the human liver
    Sonnier, M
    Cresteil, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (03): : 893 - 898
  • [4] EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER
    SCHWEIKL, H
    TAYLOR, JA
    KITAREEWAN, S
    LINKO, P
    NAGORNEY, D
    GOLDSTEIN, JA
    PHARMACOGENETICS, 1993, 3 (05): : 239 - 249
  • [5] Specific inhibition of human CYP1A2 using a targeted antibody
    Adams, DA
    Edwards, RJ
    Davies, DS
    Boobis, AR
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) : 189 - 197
  • [6] Involvement of human liver CYP1A2 in the metabolism of propofol
    Oda, Y
    Hamaoka, N
    Hase, I
    Tanaka, K
    Asada, A
    ANESTHESIOLOGY, 1999, 91 (3A) : U244 - U244
  • [7] Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype
    Jiang, Zhengwen
    Dragin, Nadine
    Jorge-Nebert, Lucia F.
    Martin, Martha V.
    Guengerich, F. Peter
    Aklillu, Eleni
    Ingelman-Sundberg, Magnus
    Hammons, George J.
    Lyn-Cook, Beverly D.
    Kadlubar, Fred F.
    Saldana, Shannon N.
    Sorter, Michael
    Vinks, Alexander A.
    Nassr, Nassr
    von Richter, Oliver
    Jin, Li
    Nebert, Daniel W.
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (05): : 359 - 367
  • [8] Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes
    Kim, Heeyeon
    Choi, Hyun Kyu
    Jeong, Tae Cheon
    Jahng, Yurngdong
    Kim, Dong Hyun
    Lee, Seung-Ho
    Lee, Sangkyu
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 51 : 33 - 37
  • [9] Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes
    Paudel, Sanjita
    Jo, Hyoje
    Lee, Taeho
    Lee, Sangkyu
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (05) : 365 - 371
  • [10] Synergistic role of the human CYP1A2 promoter and dioxin response element in the induction of CYP1A2
    Raucy, Judy L.
    Kramer, Kyle
    Quattrochi, Linda C.
    DRUG METABOLISM REVIEWS, 2006, 38 : 114 - 114
12345